This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

FOLFIRI-Avastin Regimen

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What the FOLFIRI-Avastin Regimen Means

The FOLFIRI-Avastin Regimen is a cancer treatment that combines chemotherapy drugs with a targeted therapy drug. It is mainly used for colorectal cancer that has spread to other parts of the body, known as metastatic colorectal cancer. The regimen includes four drugs: leucovorin (also called folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab (known by the brand name Avastin). Each drug works in a different way to attack cancer cells, aiming to slow or stop their growth.

Why This Treatment Can Matter in Cancer Care

Using a combination of drugs like in the FOLFIRI-Avastin Regimen can be more effective than using a single drug because the different medicines target cancer cells through multiple mechanisms. Bevacizumab is a targeted therapy that works by blocking the growth of blood vessels that feed tumors, while the chemotherapy drugs damage the cancer cells directly. This approach can help control cancer spread and improve symptoms for some patients.

What Patients Might See or Hear About This Term

Patients may encounter the term FOLFIRI-Avastin Regimen in medical reports, treatment plans, or discussions with their healthcare team. It might also appear under similar names like FOLFIRI-Bevacizumab or FOLFIRI-Bevacizumab Regimen. Because the names are very similar, it’s helpful to ask your care team to explain exactly what drugs are included and how they fit into your treatment.

Where This Term May Appear

This term can show up in various places such as your medical records, chemotherapy treatment plans, clinical trial descriptions, or drug information pages. It is often used to describe a specific combination of drugs prescribed for colorectal cancer treatment.

What the Term Does Not Automatically Mean

Seeing the term FOLFIRI-Avastin Regimen does not by itself tell you the stage of cancer, how well the treatment will work, or what side effects you might experience. It is simply the name of a drug combination. Treatment decisions depend on many factors unique to each person, so it’s important not to assume anything beyond the drug names without talking to your doctor.

Common Questions to Ask Your Care Team

If you hear this term, you might ask: What drugs are included in this regimen? How does this treatment work for my type of cancer? What are the possible side effects? How will we know if the treatment is working? Are there other treatment options? Understanding these details can help you feel more informed and involved in your care.

How to Read This Term in Context

Always consider the FOLFIRI-Avastin Regimen as part of a larger treatment plan. It is not a diagnosis or a guarantee of a specific outcome. When you see this term, ask your healthcare team to explain how it fits your personal situation, including your cancer type, stage, and overall health.

Important Safety and Context Notes

This information is educational and does not replace medical advice. The FOLFIRI-Avastin Regimen involves powerful drugs that can have significant side effects and risks. Only your healthcare team can determine if this treatment is safe and appropriate for you based on your individual health status.

Next Steps for Patients and Caregivers

If you come across the term FOLFIRI-Avastin Regimen in your care, the best next step is to talk openly with your doctors or nurses. Ask them to explain what this treatment means for you, what to expect, and how it fits into your overall cancer care. Being informed helps you make decisions and prepare for your treatment journey.

Sources

Public source information used for this glossary entry includes: